Cholinesterase inhibitors in Alzheimer's disease: a consensus view on managing treatment failure

By Emre Murat   Farlow Martin   Bullock Roger   Gauthier Serge   Grossberg George   Potkin Steven G  

Primary Care Psychiatry, Vol. 9, Iss. 1, 2004-01 ,pp. : 29-30

Informa Healthcare

Access to resources Recommend Favorite

Can cholinesterase inhibitors provide additional effects to cholinergic neurotransmission enhancement?

By López Manuela   Arias Esperanza   Sobrado Mónica   Lorrio Silvia   Roda José   Garcia Antoni  

Journal of Molecular Neuroscience, Vol. 30, Iss. 1-2, 2006-02 ,pp. : 141-144

Humana Press, Inc

Access to resources Recommend Favorite

Cholinesterase inhibitors in Alzheimer’’s disease: sooner or later or both?

By Kerwin Robert  

Future Neurology, Vol. 1, Iss. 6, 2006-11 ,pp. : 737-740

Future Medicine

Access to resources Recommend Favorite

Headache related to use of cholinesterase inhibitors: study of a Cognitive Function Clinic population

By Larner A.  

The Journal of Headache and Pain, Vol. 7, Iss. 6, 2006-12 ,pp. : 440-441

Springer Publishing Company

Access to resources Recommend Favorite

"Value for money" in treating Alzheimer's disease with the new cholinesterase inhibitors

By Shah Ajit   Jenkins Rachel  

International Journal of Psychiatry in Clinical Practice, Vol. 7, Iss. 1, 2003-01 ,pp. : 45-47

Ashgate Publishing Ltd

Access to resources Recommend Favorite